Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Body Weight ChangeSchizophreniaSchizoaffective DisorderPsychotic Disorder
Interventions
DRUG

Aripiprazole

Trial Locations (32)

Unknown

Local Institution, Little Rock

Local Institution, Anaheim

Local Institution, Cerritos

Local Institution, Garden Grove

Local Institution, National City

Local Institution, San Diego

Local Institution, New Britain

Local Institution, North Miami

Local Institution, Augusta

Local Institution, Macon

Local Institution, Hoffman Estates

Local Institution, Louisville

Local Institution, Glen Burnie

Local Institution, Haverhill

Local Institution, Worcester

Local Institution, Minneapolis

Local Institution, Brooklyn

Local Institution, Nashville

Local Institution, Austin

Local Institution, Dallas

Local Institution, DeSoto

Local Institution, San Antonio

Local Institution, Wauwatosa

Local Institution, Goibnia

Local Institution, Belo Horizonte

Local Institution, Rio de Janeiro

Local Institution, Porto Alegre

Local Institution, Botucatu

Local Institution, Sao Paulo - Sp

Local Institution, São Paulo

Local Institution, Exeter

Local Institution, Birmingham

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY